[Intravenous immunoglobulin substitution in patients with ARC and AIDS (WR 3-6)]. / Intravenöse Immunglobulinsubstitution bei Patienten mit ARC und AIDS (WR 3-6).
Immun Infekt
; 22(2): 53-5, 1994 Apr.
Article
en De
| MEDLINE
| ID: mdl-7959860
ABSTRACT
HIV-infected patients acquire a profound dysfunction in humoral and cellular immunity. This immunological impairment causes a markedly increased incidence of recurrent infections. While effective prophylaxis of Pneumocystis carinii pneumonia is available, infections with other microorganisms still cause a high rate of morbidity and mortality. Preliminary results of our randomized outpatient trial to evaluate the efficacy of intravenous immunoglobulin (IVIG) in adults demonstrate that IVIG reduces the episodes of fever, diarrhea, and the duration of hospitalization. We also found a significant reduction of mortality due to infection.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Complejo Relacionado con el SIDA
/
Síndrome de Inmunodeficiencia Adquirida
/
Inmunoglobulinas Intravenosas
Tipo de estudio:
Clinical_trials
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
De
Revista:
Immun Infekt
Año:
1994
Tipo del documento:
Article